Termination of Registration of a Class of Security Under Section 12(b) (15-12b)
August 06 2015 - 5:17PM
Edgar (US Regulatory)
________________________
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION
AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(G) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 001-36407
Alnylam Pharmaceuticals, Inc.
(Exact name of registrant as
specified in its charter)
300 Third Street, Cambridge, MA 02142; (617) 551-8200
(Address, including zip code, and
telephone number, including area code, of registrants principal executive offices)
Rights to Purchase Series A Junior
Participating Preferred Stock
(Title of each class of securities covered by this Form)
Common Stock, par value $0.01 per share
(Titles of all other classes of
securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the
appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Approximate number of holders of record as
of the certification or notice date: None
Pursuant to the requirements of the Securities Exchange Act of 1934,
Alnylam Pharmaceuticals, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
|
|
|
|
|
|
|
|
|
Date: August 6, 2015 |
|
|
|
By: Alnylam Pharmaceuticals, Inc. |
|
|
|
|
|
|
|
|
By: |
|
/s/ Michael P. Mason |
|
|
|
|
|
|
Name: Title: |
|
Michael P. Mason Vice President, Finance and
Treasurer |
Instruction: This form is required by Rules 12g-4,
12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of
Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the
signature.
Alnylam Pharmaceuticals (NASDAQ:ALNY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Alnylam Pharmaceuticals (NASDAQ:ALNY)
Historical Stock Chart
From Sep 2023 to Sep 2024